Endocrine |
|
|
Clinical Trial: Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
This study is currently recruiting patients.
|
Purpose
RATIONALE: Estrogen can stimulate the growth of breast tumor cells. Ovarian function suppression combined with hormone therapy using tamoxifen or exemestane may fight breast cancer by reducing the production of estrogen. It is not yet known whether suppression of ovarian function plus either tamoxifen or exemestane is more effective than tamoxifen alone in preventing the recurrence of hormone-responsive breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of ovarian suppression plus either tamoxifen or exemestane with that of tamoxifen alone in treating premenopausal women who have undergone surgery for hormone-responsive breast cancer.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| stage I breast cancer stage II breast cancer stage IIIA breast cancer | Drug: exemestane Drug: tamoxifen Drug: triptorelin Procedure: ablative endocrine surgery Procedure: adjuvant therapy Procedure: antiestrogen therapy Procedure: antiprogestational therapy Procedure: aromatase inhibition Procedure: endocrine therapy Procedure: hormone therapy Procedure: oophorectomy Procedure: radiation therapy Procedure: releasing factor agonist therapy | Phase III |
MedlinePlus related topics: Breast Cancer
Genetics Home Reference related topics: breast cancer
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Randomized Study of Ovarian Function Suppression in Combination With Tamoxifen Versus Ovarian Function Suppression in Combination With Exemestane Versus Tamoxifen Alone in Premenopausal Women With Endocrine-Responsive Breast Cancer
OBJECTIVES:
- Compare ovarian function suppression (by triptorelin, oophorectomy, or ovarian irradiation) in combination with tamoxifen vs ovarian function suppression in combination with exemestane vs tamoxifen alone in patients with endocrine-responsive breast cancer.
- Compare the disease-free and overall survival of patients treated with these regimens.
- Compare the quality of life, including late side effects of early menopause, of patients treated with these regimens.
- Compare the incidence of second (nonbreast) malignancies in patients treated with these regimens.
- Compare the sites of first treatment failure in patients treated with these regimens.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center, prior adjuvant/neoadjuvant chemotherapy (yes vs no), and number of positive axillary and/or internal mammary lymph nodes (0 vs 1 or more). Patients are randomized to 1 of 3 treatment arms.
- Arm I: Patients receive oral tamoxifen daily.
- Patients receive tamoxifen as in arm I and ovarian function suppression by 1 of the following treatments:
- Triptorelin intramuscularly once every 28 days
- Surgical oophorectomy
- Ovarian irradiation once daily for 4 or 5 days
- Arm III: Patients receive oral exemestane daily and ovarian function suppression as in arm II. Treatment continues for 5 years in the absence of disease progression or unacceptable toxicity.
Quality of life is assessed at baseline, every 6 months for 2 years, and then annually for 4 years.
Patients are followed every 3 months for 1 year, every 6 months for 5 years, and then annually thereafter.
PROJECTED ACCRUAL: A total of 3,000 patients (1,000 per treatment arm) will be accrued for this study within 5 years.
Eligibility
Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Histologically confirmed breast cancer
- Completely resected disease
- No clinically detectable residual loco-regional axillary disease
- Prior surgery for primary breast cancer of 1 of the following types:
- Total mastectomy with or without adjuvant radiotherapy
- Breast-conserving procedure (e.g., lumpectomy, quadrantectomy, or partial mastectomy with margins clear of invasive disease and ductal carcinoma in situ) with radiotherapy
- No more than 12 weeks since prior surgery if no adjuvant chemotherapy
- No more than 6 months since prior adjuvant chemotherapy
- Tumor confined to the breast and axillary nodes
- Tumor detected in internal mammary chain nodes that are not enlarged is allowed
- Prior neoadjuvant therapy allowed provided disease was operable prior to neoadjuvant therapy
- Axillary lymph node dissection or a negative axillary sentinel node biopsy required
- Patients with microscopically positive axillary sentinel nodes are eligible if they are randomized in a clinical study evaluating those lymph nodes
- No distant metastases
- No locally advanced inoperable breast cancer, including any of the following:
- Inflammatory breast cancer
- Supraclavicular node involvement
- Enlarged internal mammary nodes (unless pathologically negative)
- No bilateral invasive breast cancer
- No prior ipsilateral or contralateral invasive breast cancer
- Hormone receptor status:
- Estrogen and/or progesterone receptor positive
- At least 10% of the tumor cells positive by immunohistochemistry
PATIENT CHARACTERISTICS: Age
- Premenopausal
Sex
- Female
Menopausal status
- Premenopausal
- Estradiol in the premenopausal range
- Temporary chemotherapy-induced amenorrhea allowed provided premenopausal status is regained within 6 months of the final dose of chemotherapy
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
Renal
- No systemic renal disease that would preclude prolonged follow-up
Cardiovascular
- No systemic cardiovascular disease that would preclude prolonged follow-up
- No prior thrombosis (e.g., deep vein thrombosis) and/or embolism unless patient is medically suitable
Pulmonary
Other
- Not pregnant or nursing
- Fertile patients must use effective nonhormonal contraception
- No history of noncompliance to medical regimens
- No other nonmalignant systemic disease that would preclude prolonged follow-up
- No prior or concurrent malignancy except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix or bladder, or contralateral or ipsilateral carcinoma in situ of the breast
- No psychiatric, addictive, or other disorder that would preclude ability to provide informed consent
PRIOR CONCURRENT THERAPY: Biologic therapy
- Not specified
Chemotherapy
- See Disease Characteristics
Endocrine therapy
- More than 1 year since prior selective estrogen-receptor modulators (SERMs) before the breast cancer diagnosis
- More than 1 year since prior hormone replacement therapy before the breast cancer diagnosis
- No prior endocrine therapy, including adjuvant or neoadjuvant therapy, for more than 6 months after breast cancer diagnosis
- No prior gonadotropin-releasing hormone analogues for breast cancer
- No concurrent oral or transdermal hormonal therapy
- No other concurrent estrogen, progesterone, or androgens
- No other concurrent aromatase inhibitors
- No concurrent hormone replacement therapy
- No concurrent oral or other hormonal contraceptives (i.e., implants or depot injections)
- No other concurrent SERMs (e.g., raloxifene)
Radiotherapy
- See Disease Characteristics
- No prior ovarian radiotherapy
Surgery
- See Disease Characteristics
- No prior oophorectomy
- No concurrent oophorectomy unless performed as part of this study
Other
- No concurrent bisphosphonates, except in the following cases:
- Bone density is at least 1.5 standard deviations below the young adult normal mean
- Participation in a randomized clinical study testing bisphosphonates in the adjuvant breast cancer setting
- No other concurrent investigational agent
Location and Contact Information
Alabama
East Alabama Medical Center, Opelika, Alabama, 36802-3201, United States; Recruiting
MBCCOP - Gulf Coast, Mobile, Alabama, 36607, United States; Recruiting
Montgomery Cancer Center, Montgomery, Alabama, 36106-2803, United States; Recruiting
Northeast Alabama Regional Medical Center, Anniston, Alabama, 36207, United States; Recruiting
Alaska
Alaska Regional Hospital, Anchorage, Alaska, 99508, United States; Recruiting
Arizona
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, 85724, United States; Recruiting
Cancer Center of Northern Arizona at Flagstaff Medical Center, Flagstaff, Arizona, 86001, United States; Recruiting
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, 85259-5404, United States; Recruiting
CCOP - Western Regional, Arizona, Phoenix, Arizona, 85006-2726, United States; Recruiting
Mesa Lutheran Hospital, Mesa, Arizona, 85201, United States; Recruiting
Sun Health Research Institute, Sun City, Arizona, 85351, United States; Recruiting
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden), Phoenix, Arizona, 85012, United States; Recruiting
Veterans Affairs Medical Center - Tucson, Tucson, Arizona, 85723, United States; Recruiting
Arkansas
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States; Recruiting
Ben E. Owens Cancer Treatment Center at St. Bernard's Medical Center, Jonesboro, Arkansas, 72403, United States; Recruiting
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, 72913, United States; Recruiting
Highlands Oncology Group - Fayetteville, Fayetteville, Arkansas, 72703, United States; Recruiting
Jefferson Regional Medical Center, Pine Bluff, Arkansas, 71603, United States; Recruiting
North Arkansas Regional Medical Center, Harrison, Arkansas, 72601, United States; Recruiting
Sparks Regional Medical Center, Fort Smith, Arkansas, 72917-7006, United States; Recruiting
Veterans Affairs Medical Center - Little Rock, Little Rock, Arkansas, 72205, United States; Recruiting
California
California Cancer Center - Woodward Park Office, Fresno, California, 93720, United States; Recruiting
CCOP - Bay Area Tumor Institute, Oakland, California, 94609-3305, United States; Recruiting
CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, 95403, United States; Recruiting
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, 92868, United States; Recruiting
City of Hope Comprehensive Cancer Center, Duarte, California, 91010-3000, United States; Recruiting
Comprehensive Cancer Center at Desert Regional Medical Center, Palm Springs, California, 92262-5309, United States; Recruiting
Crosson Cancer Center at St. Jude Medical Center, Fullerton, California, 92835, United States; Recruiting
Doctors Medical Center, Modesto, California, 95350-4138, United States; Recruiting
General Robert Huyser Cancer Center at David Grant Medical Center, Travis Air Force Base, California, 94535, United States; Recruiting
Glendale Memorial Hospital Comprehensive Cancer Center, Glendale, California, 91204, United States; Recruiting
Huntington Cancer Center at Huntington Hospital, Pasadena, California, 91105, United States; Recruiting
John Muir Comprehensive Cancer Center at John Muir Medical Center, Walnut Creek, California, 94598, United States; Recruiting
John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, 90404, United States; Recruiting
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, 90095-6900, United States; Recruiting
Kaiser Permanente Medical Center - Sacramento, Sacramento, California, 95825, United States; Recruiting
Loma Linda University Cancer Institute at Loma Linda University Medical Center, Loma Linda, California, 92354, United States; Recruiting
Los Angeles Oncologic Institute, Los Angeles, California, 90057, United States; Recruiting
Mercy Regional Cancer Center at Mercy Medical Center, Redding, California, 96049, United States; Recruiting
Methodist Hospital of Southern California, Arcadia, California, 91066-6016, United States; Recruiting
Naval Medical Center - San Diego, San Diego, California, 92134-3202, United States; Recruiting
North Bay Cancer Center, Fairfield, California, 94533, United States; Recruiting
Northridge Hospital, Northridge, California, 91324, United States; Recruiting
Presbyterian Intercommunity Hospital, Whittier, California, 90602, United States; Recruiting
Providence Saint Joseph Medical Center - Burbank, Burbank, California, 91505, United States; Recruiting
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, 92093-0658, United States; Recruiting
Redding Cancer Treatment Center, Redding, California, 96001, United States; Recruiting
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States; Recruiting
Sansum Medical Clinic, Santa Barbara, California, 93105, United States; Recruiting
Scripps Cancer Center at Scripps Clinic, La Jolla, California, 92037, United States; Recruiting
Sierra Nevada Cancer Center at Sierra Nevada Memorial Hospital, Grass Valley, California, 95945, United States; Recruiting
St. Joseph Hospital Regional Cancer Center - Orange, Orange, California, 92868-3849, United States; Recruiting
St. Joseph's Regional Cancer Center, Stockton, California, 95204, United States; Recruiting
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, 94305-5750, United States; Recruiting
Sutter Cancer Center, Sacramento, California, 95816, United States; Recruiting
Sutter Health Western Division Cancer Research Group, Greenbrae, California, 94904, United States; Recruiting
UCSF Comprehensive Cancer Center, San Francisco, California, 94115, United States; Recruiting
University of California Davis Cancer Center, Sacramento, California, 95817, United States; Recruiting
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, 90033, United States; Recruiting
Veterans Affairs Medical Center - San Diego, San Diego, California, 92161, United States; Recruiting
Veterans Affairs Medical Center - San Francisco, San Francisco, California, 94121, United States; Recruiting
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, 94553, United States; Recruiting
Colorado
Exempla Lutheran Medical Center, Wheat Ridge, Colorado, 80033, United States; Recruiting
Memorial Hospital Cancer Center, Colorado Springs, Colorado, 80909, United States; Recruiting
Poudre Valley Hospital, Fort Collins, Colorado, 80524, United States; Recruiting
St. Anthony Central Hospital, Denver, Colorado, 80204-1335, United States; Recruiting
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center, Grand Junction, Colorado, 81502-1628, United States; Recruiting
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora, Colorado, 80010, United States; Recruiting
Veterans Affairs Medical Center - Denver, Denver, Colorado, 80220, United States; Recruiting
Connecticut
St. Vincent's Medical Center, Bridgeport, Connecticut, 06606, United States; Recruiting
Delaware
CCOP - Christiana Care Health Services, Newark, Delaware, 19713, United States; Recruiting
District of Columbia
Lombardi Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, 20007, United States; Recruiting
MBCCOP - Howard University Cancer Center, Washington, District of Columbia, 20060, United States; Recruiting
Walter Reed Army Medical Center, Washington, District of Columbia, 20307-5001, United States; Recruiting
Florida
Bethesda/South Florida Bone Marrow Stem Cell Transplant Institute, Boynton Beach, Florida, 33437-3750, United States; Recruiting
Broward General Medical Center, Fort Lauderdale, Florida, 33316, United States; Recruiting
CCOP - Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States; Recruiting
Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States; Recruiting
Hematology Oncology Associates, Lake Worth, Florida, 33461, United States; Recruiting
JFK Medical Center, Atlantis, Florida, 33462, United States; Recruiting
Mayo Clinic - Jacksonville, Jacksonville, Florida, 32224, United States; Recruiting
Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, 33021, United States; Recruiting
Palm Beach Cancer Institute - West Palm Beach, West Palm Beach, Florida, 33401, United States; Recruiting
Sacred Heart Cancer Center at Sacred Heart Hospital, Pensacola, Florida, 32504, United States; Recruiting
University Community Hospital, Tampa, Florida, 33613, United States; Recruiting
University of Florida Shands Cancer Center, Gainesville, Florida, 32610-0277, United States; Recruiting
Veterans Affairs Medical Center - Tampa (Haley), Tampa, Florida, 33612, United States; Recruiting
West Florida Cancer Institute - Pensacola, Pensacola, Florida, 32514, United States; Recruiting
Georgia
Augusta Oncology Associates, Augusta, Georgia, 30901, United States; Recruiting
CCOP - Atlanta Regional, Atlanta, Georgia, 30342-1701, United States; Recruiting
Dwight David Eisenhower Army Medical Center, Fort Gordon, Georgia, 30905-5650, United States; Recruiting
Northeast Georgia Medical Center, Gainesville, Georgia, 30501-3741, United States; Recruiting
Pearlman Comprehensive Cancer Center at South Georgia Medical Center, Valdosta, Georgia, 31602, United States; Recruiting
Phoebe Cancer Center at Phoebe Putney Memorial Hospital, Albany, Georgia, 31701, United States; Recruiting
Hawaii
MBCCOP - Hawaii, Honolulu, Hawaii, 96813, United States; Recruiting
Idaho
Hematology Oncology Associates of Eastern Idaho, Idaho Falls, Idaho, 83404, United States; Recruiting
St. Luke's Regional Medical Center, Boise, Idaho, 83712, United States; Recruiting
Illinois
BroMenn Regional Medical Center, Normal, Illinois, 61761, United States; Recruiting
Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, 60153-5500, United States; Recruiting
CCOP - Carle Cancer Center, Urbana, Illinois, 61801, United States; Recruiting
CCOP - Central Illinois, Decatur, Illinois, 62526, United States; Recruiting
CCOP - Evanston, Evanston, Illinois, 60201, United States; Recruiting
CCOP - Illinois Oncology Research Association, Peoria, Illinois, 61615-7828, United States; Recruiting
Center for Cancer Care at OSF Saint Anthony Medical Center, Rockford, Illinois, 61108, United States; Recruiting
Hematology Oncology Consultants Ltd., Naperville, Illinois, 60540, United States; Recruiting
La Grange Oncology Associates, La Grange, Illinois, 60525, United States; Recruiting
Louis A. Weiss Memorial Hospital, Chicago, Illinois, 60640, United States; Recruiting
MBCCOP - University of Illinois at Chicago, Chicago, Illinois, 60612, United States; Recruiting
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, 60611, United States; Recruiting
Saint Mary's Hospital, Centralia, Illinois, 62801, United States; Recruiting
University of Chicago Cancer Research Center, Chicago, Illinois, 60637-1470, United States; Recruiting
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, 60612, United States; Recruiting
Veterans Affairs Medical Center - Hines, Hines, Illinois, 60141, United States; Recruiting
West Suburban Center for Cancer Care, River Forest, Illinois, 60305, United States; Recruiting
Indiana
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, 46601, United States; Recruiting
Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, 46885-5099, United States; Recruiting
Iowa
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, 52403-1206, United States; Recruiting
CCOP - Iowa Oncology Research Association, Des Moines, Iowa, 50309-1016, United States; Recruiting
Genesis Regional Cancer Center at Genesis Medical Center, Davenport, Iowa, 52803, United States; Recruiting
Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, 52242-1009, United States; Recruiting
Siouxland Hematology-Oncology, Sioux City, Iowa, 51101-1733, United States; Recruiting
Kansas
CCOP - Wichita, Wichita, Kansas, 67214-3882, United States; Recruiting
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, 66160-7353, United States; Recruiting
Salina Regional Health Center, Salina, Kansas, 67401, United States; Recruiting
St. Francis Comprehensive Cancer Center, Topeka, Kansas, 66606, United States; Recruiting
Veterans Affairs Medical Center - Wichita, Wichita, Kansas, 67218, United States; Recruiting
Kentucky
Baptist Hospital East - Louisville, Louisville, Kentucky, 40207, United States; Recruiting
Cancer Care at Our Lady of Bellefonte Hospital, Ashland, Kentucky, 41101, United States; Recruiting
Central Baptist Hospital, Lexington, Kentucky, 40503, United States; Recruiting
James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, 40202, United States; Recruiting
Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington, Kentucky, 40536-0084, United States; Recruiting
Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, 40502-2236, United States; Recruiting
Louisiana
Cancer Center at Thibodaux Regional Medical Center, Thibodaux, Louisiana, 70302-1118, United States; Recruiting
Cancer Treatment Center at Christus Schumpert St. Mary Place, Shreveport, Louisiana, 71101-0000, United States; Recruiting
CCOP - Ochsner, New Orleans, Louisiana, 70121, United States; Recruiting
Christus St. Frances Cabrini Center for Cancer Care, Alexandria, Louisiana, 71301, United States; Recruiting
Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, 71130-3932, United States; Recruiting
MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, 70112, United States; Recruiting
New Orleans Cancer Institute At Memorial Medical Center, New Orleans, Louisiana, 70115, United States; Recruiting
Our Lady of Lourdes Regional Medical Center, Lafayette, Louisiana, 70502-4027, United States; Recruiting
Rapides Regional Medical Center, Alexandria, Louisiana, 71301-7888, United States; Recruiting
Tulane Cancer Center at Tulane University Hospital and Clinic, New Orleans, Louisiana, 70112, United States; Recruiting
Veterans Affairs Medical Center - New Orleans, New Orleans, Louisiana, 70112, United States; Recruiting
Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, 71101-4295, United States; Recruiting
Willis-Knighton Cancer Center at Willis-Knighton Medical Center, Shreveport, Louisiana, 71103-3951, United States; Recruiting
Maryland
Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland, 21225, United States; Recruiting
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, 21201, United States; Recruiting
St. Joseph Medical Center, Towson, Maryland, 21204, United States; Recruiting
Massachusetts
Berkshire Hematology Oncology, P.C., Pittsfield, Massachusetts, 01201, United States; Recruiting
Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States; Recruiting
Cancer Research Center at Boston Medical Center, Boston, Massachusetts, 02118, United States; Recruiting
Caritas Holy Family Hospital, Methuen, Massachusetts, 01844, United States; Recruiting
Caritas St. Elizabeth's Medical Center, Boston, Massachusetts, 02135, United States; Recruiting
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States; Recruiting
UMASS Memorial Cancer Center - University Campus, Worcester, Massachusetts, 01655, United States; Recruiting
Michigan
Alpena General Hospital, Alpena, Michigan, 49707, United States; Recruiting
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201-1379, United States; Recruiting
Bay Regional Medical Center, Bay City, Michigan, 48708, United States; Recruiting
Breslin Cancer Center at Ingham Regional Medical Center, Lansing, Michigan, 48910, United States; Recruiting
CCOP - Beaumont, Royal Oak, Michigan, 48073-6769, United States; Recruiting
CCOP - Grand Rapids, Grand Rapids, Michigan, 49503, United States; Recruiting
CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, 48106, United States; Recruiting
Detroit Medical Center at Wayne State University, Detroit, Michigan, 48201, United States; Recruiting
Foote Hospital, Jackson, Michigan, 49201, United States; Recruiting
Josephine Ford Cancer Center at Henry Ford Health System, Detroit, Michigan, 48202, United States; Recruiting
Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph, Saint Joseph, Michigan, 49085, United States; Recruiting
Mount Clemens General Hospital, Mount Clemens, Michigan, 48043, United States; Recruiting
Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, 48123-2500, United States; Recruiting
Providence Cancer Institute at Providence Hospital - Southfield, Southfield, Michigan, 48075, United States; Recruiting
St. Joseph Mercy Hospital, Pontiac, Michigan, 48341-2985, United States; Recruiting
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109-0948, United States; Recruiting
Upper Michigan Cancer Center at Marquette General Hospital, Marquette, Michigan, 49855, United States; Recruiting
Veterans Affairs Medical Center - Detroit, Detroit, Michigan, 48201-1932, United States; Recruiting
Minnesota
CCOP - Duluth, Duluth, Minnesota, 55805, United States; Recruiting
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, 55416, United States; Recruiting
Coborn Cancer Center, Saint Cloud, Minnesota, 56303, United States; Recruiting
Mayo Clinic Cancer Center, Rochester, Minnesota, 55905, United States; Recruiting
University of Minnesota Cancer Center, Minneapolis, Minnesota, 55455, United States; Recruiting
Veterans Affairs Medical Center - Minneapolis, Minneapolis, Minnesota, 55417, United States; Recruiting
Mississippi
Keesler Medical Center - Keesler Air Force Base, Keesler AFB, Mississippi, 39534-2576, United States; Recruiting
Medical Oncology Group, P.A., Gulfport, Mississippi, 39501, United States; Recruiting
Regional Cancer Center at Singing River Hospital, Pascagoula, Mississippi, 39581, United States; Recruiting
University of Mississippi Medical Center, Jackson, Mississippi, 39216-4505, United States; Recruiting
Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, 39216, United States; Recruiting
Missouri
Audrain Medical Center, Mexico, Missouri, 65265, United States; Recruiting
Cancer Care Central Missouri, Sedalia, Missouri, 65301, United States; Recruiting
CCOP - Cancer Research for the Ozarks, Springfield, Missouri, 65807, United States; Recruiting
CCOP - Kansas City, Kansas City, Missouri, 64131, United States; Recruiting
CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, 63141, United States; Recruiting
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, 65203, United States; Recruiting
Missouri Baptist Cancer Center, Saint Louis, Missouri, 63131, United States; Recruiting
Saint Louis University Cancer Center, Saint Louis, Missouri, 63110, United States; Recruiting
Siteman Cancer Center at Barnes-Jewish Hospital, Saint Louis, Missouri, 63110, United States; Recruiting
Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, 65201, United States; Recruiting
Veterans Affairs Medical Center - Kansas City, Kansas City, Missouri, 64128, United States; Recruiting
Montana
CCOP - Montana Cancer Consortium, Billings, Montana, 59101, United States; Recruiting
Nebraska
Cancer Center at the Good Samaritan Health Systems, Kearney, Nebraska, 68848-1990, United States; Recruiting
UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, 68198-7680, United States; Recruiting
Nevada
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas, Nevada, 89106, United States; Recruiting
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Web site for additional information
Record last reviewed: March 2005
Last Updated: March 28, 2005
Record first received: August 6, 2003
ClinicalTrials.gov Identifier: NCT00066690
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Aromatherapy for the Glandular System (HealthWorld)
- Disorders of the Endocrine System (HealthWorld)

Not Signed In -
